1
Clinical Trials associated with QLS5212 / Not yet recruitingPhase 1 A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of QLS5212 Monotherapy in Participants With Advanced Solid Tumors
This is a Phase 1, open-label, multi-center, first-in-human, dose escalation and cohort expansion study evaluating multiple doses and schedules of intravenously administered QLS5212 in participants with unresectable locally, advanced or metastatic cancer.
100 Clinical Results associated with QLS5212
100 Translational Medicine associated with QLS5212
100 Patents (Medical) associated with QLS5212
100 Deals associated with QLS5212